NEWS
View news from our Featured Companies.
Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients
This is the longest Niagen NR clinical trial to date spanning two years and showcases that long-term Niagen NR is safe and well tolerated LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), one of the global authorities on Nicotinamide Adenine Dinucleotide (NAD+) and healthy...
Scientific Industries Reports Financial Results for Third Quarter 2023
Bioprocessing Operations Launched Revolutionary New ProductsBioprocessing Revenue Generated From Legacy Products Up 36%Vivid Pill Counters YTD Revenue Up 75%BOHEMIA, NY / November 14, 2023 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and a...
Precision Optics Reports First Quarter Fiscal Year 2024 Financial Results
Conference Call Scheduled for today, November 14, 2023, at 5:00pm ET. GARDNER, Mass., Nov. 14, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries,...
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
Q1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in Q1 2024Q1 2024 ADHD net revenue up 31% compared to Q1 2023$20.0 million cash balance at September 30, 2023Company to host conference call today at...
Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights
- RECOVER global Phase 3 trial successfully met all primary and secondary endpoints with statistically significant and clinically meaningful reductions across all major symptom domains at week 4 with 50 mg of brilaroxazine vs. placebo in schizophrenia - - Consistent...
Greenfire Resources Announces Q3 2023 Results, Operational Update, Acceleration of Additional Drilling into 2023 at the Expansion Asset and Two-Year Drilling Commitment to Support Sustained Production Growth
Calgary, Alberta--(November 14, 2023) - Greenfire Resources Ltd. (NYSE: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta, Canada,...
Modular Medical to Attend the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
SAN DIEGO, CA / November 14, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today...
NeurAxis Secures $3 Million Financing
CARMEL, Ind., Nov. 14, 2023 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced it has...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
PORTLAND, Maine, Nov. 13, 2023 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
INVO Reports Record Third Quarter 2023 Financial Results
Company Expects to Host Conference Call Shortly After November 20, 2023 Following the Progress of Certain Closing Conditions Pertaining to the Announced Merger Agreement with NAYA Biosciences SARASOTA, Fla., Nov. 13, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO)...
Greenfire Resources to Announce Q3 2023 Results and Host Conference Call
Calgary, Alberta--(November 13, 2023) - Greenfire Resources Ltd. (NYSE: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta, Canada,...
Scientific Industries to Report Third Quarter 2023 Financial Results on November 14, 2023
Investor Call to be held Wednesday, November 15th at 11:00 AM Eastern TimeBOHEMIA, NY / November 13, 2023 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it will...
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
SARASOTA, Fla. and AVENTURA, Fla., Nov. 10, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO"), a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and NAYA Biosciences Inc. ("NAYA"), a company dedicated to...
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company’s Common Stock Purchase Warrants
SARASOTA, Fla., Nov. 9, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services company focused on expanding access to advanced fertility treatment worldwide with its INVOcell® medical device and the intravaginal culture...
InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
SenesTech Announces Third Quarter 2023 Financial Results
Revenue Growth Up 44%; Net Loss Improved by Almost $700,000 Company to Begin Shipments of Evolve Soft Bait Next Week Expected to Be a Key Driver of Revenue Growth PHOENIX, Nov. 9, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"),...
Precision Optics Announces the Receipt of a New Production Order for Robotic Laparoscopy System
GARDNER, Mass., Nov. 9, 2023 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of an $890,000 initial production order for a...
Cadrenal Therapeutics Provides Third Quarter 2023 Corporate Update
PONTE VEDRA, Fla., Nov. 9, 2023 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) ("Cadrenal Therapeutics" or the "Company") a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart...
LiqTech International Announces Third Quarter 2023 Financial Results
BALLERUP, Denmark, Nov. 9, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the third quarter of 2023 for the...
S&W Announces First Quarter Fiscal 2024 Financial Results
LONGMONT, Colo., Nov. 9, 2023 -- S&W Seed Company (Nasdaq: SANW) today announced financial results for the three months ended September 30, 2023. Financial Highlights Revenue for the first quarter of fiscal 2024 was $16.4 million, a 17.3% decrease compared to the...
Mogo Reports Results for Q3 2023
Payment volume up 30% year-over-year to $2.4 billion Revenue of $16.2 million, up sequentially as top-line growth resumes Adjusted EBITDA1 of $2.1 million, a $4.9 million increase from Q3 2022; 6th quarter in a row of increasing Adjusted EBITDA Cash and total...
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023
LOS ANGELES - ChromaDex Corporation (NASDAQ: CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) and healthy aging research, announced today that they will be participating in Renmark Financial Communications Inc.'s live Virtual Non-Deal Roadshow...
Kiora Pharmaceuticals Reports Q3 2023 Results; Expanding Clinical Development of KIO-301 for Inherited Retinal Diseases Based on Encouraging Results of ABACUS-1 Study in Retinitis Pigmentosa
Encinitas, California--(November 9, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced its third quarter 2023 financial results and is providing an update on its plans to advance clinical development of KIO-301 for other...
ChromaDex Corporation Reports Third Quarter 2023 Financial Results
Total net sales of $19.5 million, a gross margin of 61.4% and a net loss of $1.0 million while achieving a positive Adjusted EBITDA of $0.5 million and positive operating cash flows for the three months ended September 30, 2023. LOS ANGELES - ChromaDex Corp. (NASDAQ:...
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte’s Technology Fast 500™ for Third Consecutive Year
Ranked 118th Fastest Growing Company in North AmericaRanked 23rd Fastest Growing Life Sciences CompanyDENVER, CO / November 8, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics,...